MDxHealth SA is a precision diagnostics company that offers innovative solutions for urologic care to clients globally. They provide two non-invasive tests, SelectMDx and ConfirmMDx, that physicians use to efficiently detect prostate cancer, reducing the need for invasive procedures that can lead to complications. Formerly known as OncoMethylome Sciences SA, the company changed its name to MDxHealth SA in 2010 and is based in Herstal, Belgium.